CEBP Infection and Cancer: Biology, Therapeutics, and Prevention Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horn, E. P.
Right arrow Articles by Caporaso, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horn, E. P.
Right arrow Articles by Caporaso, N. E.

Cancer Epidemiology Biomarkers & Prevention, Vol 4, Issue 5 529-533, Copyright © 1995 by American Association for Cancer Research


ARTICLES

A study of gender-based cytochrome P4501A2 variability: a possible mechanism for the male excess of bladder cancer

EP Horn, MA Tucker, G Lambert, D Silverman, D Zametkin, R Sinha, T Hartge, MT Landi and NE Caporaso
Harvard Medical School, Boston, Massachusetts 02115, USA.

One hypothesis for the well known gender difference in bladder cancer risk is that males and females metabolize carcinogens differently. The caffeine breath test (CBT) was performed on a group of healthy men and women to determine whether there was a gender difference in P4501A2 activity. Results consistent with previous data suggest an elevation of CBT in men were observed, although this increase was not statistically significant. Among women, however, there was a significant difference between nulliparous and parous women(P = 0.03). Parous women had CBT values similar to men, whereas the results of women who had never given birth were lower. Confirming earlier studies, women taking oral contraceptives had low CBT values. Our data suggest an effect of recent caffeine consumption, with heavy coffee drinkers having higher rates of caffeine clearance. Adjustment for other weak effects, such as age, exposure to environment cigarette smoke, history of smoking, recent meat and cruciferous vegetable consumption, and use of alcohol or other medications, did not alter these findings. The finding of a difference between parous and nulliparous women requires further study.


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
C. McLean and T. E. Graham
Effects of exercise and thermal stress on caffeine pharmacokinetics in men and eumenorrheic women
J Appl Physiol, October 1, 2002; 93(4): 1471 - 1478.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
J. W. Lampe and S. Peterson
Brassica, Biotransformation and Cancer Risk: Genetic Polymorphisms Alter the Preventive Effects of Cruciferous Vegetables
J. Nutr., October 1, 2002; 132(10): 2991 - 2994.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. Chen, S. Ricks, D. R. Doody, E.D. Fitzgibbons, P. L. Porter, and S. M. Schwartz
N-Acetyltransferase 2 polymorphisms, cigarette smoking and alcohol consumption, and oral squamous cell cancer risk
Carcinogenesis, December 1, 2001; 22(12): 1993 - 1999.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
B. Sinués, M. A. Sáenz, J. Lanuza, M. L. Bernal, A. Fanlo, J. L. Juste, and E. Mayayo
Five Caffeine Metabolite Ratios to Measure Tobacco-induced CYP1A2 Activity and Their Relationships with Urinary Mutagenicity and Urine Flow
Cancer Epidemiol. Biomarkers Prev., February 1, 1999; 8(2): 159 - 166.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
M. G. Sturgill and G. H. Lambert
Xenobiotic-induced hepatotoxicity: mechanisms of liver injury and methods of monitoring hepatic function
Clin. Chem., August 1, 1997; 43(8): 1512 - 1526.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.